Molecular Devices Announces Development of a Novel Platform Combining a Plate Reader with an Imaging Cytometer

Molecular Devices announced today it has developed an addition to the SpectraMax® product line. The new multi-mode microplate platform will have an imaging cytometer option, adding rich cellular resolution assays and visualization to well-based intensity readings. The new system will make cytometry more accessible to a wider audience, providing researchers with cellular analysis capability without the need for investment in complex imaging systems. With the ability to inspect both bright-field and fluorescent images, it will provide insight into phenotypic changes that are important for understanding cytotoxicity, cell proliferation, and protein expression.

The imaging cytometer option will provide rapid access to vital cell-based data without the complexity that is typical of automated microscopy and flow cytometry. The enhanced SoftMax® Pro Microplate Data Acquisition and Analysis Software will provide the user interface and lend step-by-step guidance, from initial setup of image acquisitions to comprehensive data analysis.

“This new platform is exemplary of our commitment to providing a flexible instrument that is capable of performing many different types of assays,” said Chris Kier, Ph.D, Molecular Devices Director of Product Management, Bioimaging. “The new imaging cytometer option will allow researchers to collapse their workflow by keeping their cell-based research within the lab and on the same instrument when requiring both cellular resolution assays and standard plate assays.”